BRAF inhibitors Vemurafenib (Zelboraf) Dabrafenib (Tafinlar) Encorafenib (Braftovi) MEK inhibitors Trametinib (Mekinist) Cobimetinib (Cotellic) Binimetinib (Mektovi) Tyrosine kinase inhibitors (c-Kit inhibitors) Imatinib (Gleevec) Nilotinib (Tasigna)